Search Results 91-100 of 16402 for infliximab
Latest stories. Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 348 · 349 · 350 · 351 ...
Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 348 · 349 · 350 · 351 · Last · Sign up to receive email ...
These include tumor necrosis factor-alpha (TNFα) inhibitors (certolizumab, infliximab, adalimumab), anti-integrin agents (vedolizumab, natalizumab), and ...
In a new study published in[...] Latest stories. Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First ...
Latest stories. Gastroenterology. Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 351 · 352 · 353 · 354 ...
Crohn's Disease Study on Infliximab, Azathioprine. Shawn Bishop. October 1, 2008. First · Previous ... 353 · 354 · 355 · 356 · Last · Sign up to receive email ...
found that infliximab (Remicade®) administered alone (monotherapy) or in combination with azathioprine is a more effective treatment for patients with moderate ...
ROCHESTER, Minn. — A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of ...
This includes adalimumab (Humira®), anakinra (Kineret®), certolizumab (Cimzia®), etanercept (Enbrel®), golimumab (Simponi®), infliximab (Remicade ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!